Mergers & Acquisitions
Aug. 17, 2006
Shareholders Act to Weaken Boards' Poison Pill Against Takeovers
Forum Column - For the first time in perhaps more than a decade, Institutional Shareholder Services, the most prominent advisory firm that evaluates public-company board candidacies and board and shareholder proposals, recently reported that less than 50 percent of the 500 biggest companies traded in the United States have poison-pill provisions.
By James E. Basta
For the first time in perhaps more than a decade, Institutional Shareholder Services, the most prominent advisory firm that evaluates public-company board candidacies and board and shareholder proposals, recently reported that less than 50 percent of the 500 biggest companies traded in the United States have poison-pill provisions. That percentage was as high as 68 percent only a few years ago.
...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In